SCHEMBL7864577

SCHEMBL7864577

COC(=O)c1cc(Br)cc(N(c2ccccc2)S(C)(=O)=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.44
NOTUM Q6P988 1/20 0.43
TSHR P16473 2/20 0.42
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
PTGS2 P35354 1/20 0.39
POLB P06746 1/20 0.39
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38
TUBB8 Q3ZCM7 1/20 0.38
TUBA3E Q6PEY2 1/20 0.38
TUBA1A Q71U36 1/20 0.38
TUBA1C Q9BQE3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13229340 0.90 TSHR (0.49) TSHRKMT2AMEN1L3MBTL1PTGS2
SCHEMBL13229343 0.86 TSHR (0.45) TSHRKMT2AMEN1L3MBTL1PTGS2
SCHEMBL5720761 0.86 RECQL (0.39) ACLYTSHRKMT2AMEN1L3MBTL1
SCHEMBL5720842 0.86 CA12 (0.36) ACLYTSHRKMT2AMEN1L3MBTL1
SCHEMBL5928548 0.85 TSHR (0.44) TSHRKMT2AMEN1PTGS2POLB
SCHEMBL7857856 0.85 BACE1 (0.45) TSHRKMT2AMEN1L3MBTL1PTGS2
SCHEMBL5720749 0.84 KDM4E (0.43) TSHRKMT2AMEN1L3MBTL1PTGS2
SCHEMBL5720754 0.83 POLB (0.52) TSHRKMT2AMEN1PTGS2POLB
SCHEMBL5928542 0.83 CTSD (0.49) TSHRL3MBTL1HPGDGAALMNA
SCHEMBL5720751 0.83 CTSD (0.46) TSHRKMT2AMEN1L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476764-B2 Phenylcarboxyamides as beta-secretase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-13 US disclosed
US-7476764-B2 Phenylcarboxyamides as beta-secretase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-13 US disclosed
US-20070032470-A1 Novel phenylcarboxyamides as beta-secretase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-02-08 US disclosed
US-20070032470-A1 Novel phenylcarboxyamides as beta-secretase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032470-A1 Novel phenylcarboxyamides as beta-secretase inhibitors BACE1, APP, BACE2 ACLY 1256/4885NOTUM 506/4885TSHR 4580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.